Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT03199885||Recruiting||Paclitaxel, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Patients With Metastatic Breast Cancer||
||NIH / Other||
||600||All||18 Years and older (Adult, Older Adult)||NCT03199885||NCI-2017-01119
|March 12, 2019||December 31, 2020||December 31, 2020||June 27, 2017||August 20, 2019||